COMPULSORY ACQUISITION OF SHARES IN WEIFA ASA
· Reference is made to the stock exchange announcement made by Karo Pharma AB ("Karo Pharma") on 6 October 2017 regarding completion of the voluntary offer (the "Voluntary Offer") for the shares in Weifa ASA ("Weifa"). · Karo Pharma currently owns 35,553,352 shares in Weifa representing 97.48 % of Weifa's share capital and voting rights. · The board of directors of Karo Pharma has pursuant to Section 4-25 of the Norwegian Public Limited Companies Act and Section 6-22 of the Norwegian Securities Trading Act (the "STA") resolved to carry out a compulsory acquisition of all the